Cargando…
Pediatric medulloblastoma express immune checkpoint B7-H3
PURPOSE: Medulloblastomas (MB) are highly malignant brain tumors that predominantly occur in young infants. Immunotherapy to boost the immune system is emerging as a novel promising approach, but is often hampered by inhibitory immune checkpoints. In the present study, we have studied immune checkpo...
Autores principales: | Li, S., Poolen, G. C., van Vliet, L. C., Schipper, J. G., Broekhuizen, R., Monnikhof, M., Van Hecke, W., Vermeulen, J. F., Bovenschen, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107433/ https://www.ncbi.nlm.nih.gov/pubmed/34988920 http://dx.doi.org/10.1007/s12094-021-02762-y |
Ejemplares similares
-
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
por: Vermeulen, Jeroen F., et al.
Publicado: (2017) -
Cellular immunotherapy for medulloblastoma
por: Schakelaar, Michael Y, et al.
Publicado: (2022) -
Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors
por: Vermeulen, Jeroen F., et al.
Publicado: (2016) -
MEDB-76. Evaluating the B7-H3 checkpoint in Medulloblastoma
por: Moziak, Kirsten, et al.
Publicado: (2022) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Voskamp, Marije J., et al.
Publicado: (2021)